"Ideal" parathyroid hormone in erythropoietin-stimulating agents-resistant anemia [0.03%]
特立帕肽治疗促红细胞生成素无效的贫血患者
Bilal Ashraf,Taha Bat,Olga K Weinberg et al.
Bilal Ashraf et al.
Erythropoietin-stimulating agents (ESAs) have revolutionized anemia treatment in end-stage renal disease (ESRD), but ESA resistance is increasingly identified. Secondary hyperparathyroidism (SHP) is one cause of ESA resistance. We describe ...
Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T-cell therapy for mantle cell lymphoma [0.03%]
接受CD19嵌合抗原受体T细胞治疗套细胞淋巴瘤患者的淋巴细胞形态学变化
Maria A V Marzolini,Lorna Neill,Maeve O&#x;Reilly et al.
Maria A V Marzolini et al.
Transient left ventricular dysfunction following chimeric antigen receptor T-cell-mediated encephalopathy: A form of stress cardiomyopathy [0.03%]
嵌合抗原受体T细胞引起的脑病后出现左心室功能短暂障碍：应激性心肌病的一种形式
Adam Khorasanchi,Amir M Ansari,Wendy Bottinor et al.
Adam Khorasanchi et al.
Chimeric antigen receptor (CAR) T-cell therapy represents a new strategy in treating lymphoid malignancies, such as relapsed-refractory diffuse large B-cell lymphoma (DLBCL). Several toxicities including cytokine release syndrome (CRS), neu...
Case Reports
EJHaem. 2021 Dec 14;3(1):231-234. DOI:10.1002/jha2.369 2021
18FDG-avid cholesterol granuloma mimicking residual aggressive lymphoma after chemotherapy [0.03%]
18FDG阴性的胆固醇肉芽肿类似化疗后残余的侵袭性淋巴瘤
Lorenzo Falchi,Filiz Sen
Lorenzo Falchi
Vexas: A new syndrome not always associated with hemopathy [0.03%]
血管性血友病因子诱发的自身免疫综合征(VEXAS综合征)：并非总是伴有血液学异常的新症候群
Benoît Thomas,Julien Campagne
Benoît Thomas
Revised international staging system allocation in the ICARIA-MM study: Practical challenges and impact on outcome [0.03%]
国际多发性骨髓瘤研究（ICARIA-MM）中的修订分期系统的实际应用挑战及其对结果的影响
Paul G Richardson,Aurore Perrot,Hiroyuki Takamatsu;ICARIA‐MM study group
Paul G Richardson
Cerebrospinal fluid infiltration of primary cutaneous gamma delta T-cell lymphoma [0.03%]
原发性皮肤γδT细胞淋巴瘤脑脊液侵犯
Yoshikazu Hori,Yu Aruga,Chiaki Ikeda et al.
Yoshikazu Hori et al.
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone [0.03%]
共有的突变产生T细胞淋巴瘤、B细胞淋巴瘤和骨髓增生异常综合征：同一个原始克隆产生的三系肿瘤发生
Kyoko Yoshihara,Yasuhito Nannya,Ikuo Matsuda et al.
Kyoko Yoshihara et al.
A 64-year-old man with angioimmunoblastic T-cell lymphoma (AITL) subsequently developed diffuse large B-cell lymphoma (DLBCL) and myelodysplastic syndrome (MDS). Genomic profiling of AITL, DLBCL, and MDS samples revealed that the tumor cell...
Case Reports
EJHaem. 2021 Dec 3;3(1):211-214. DOI:10.1002/jha2.354 2021
Plasma cell morphology as a trigger for the diagnosis of adult Fanconi syndrome [0.03%]
浆细胞形态在成人范可尼综合征诊断中的作用
Ibtisam Abdullah,Johan Niemann
Ibtisam Abdullah
Transverse myelitis after anti-CD19 directed CAR T cell therapy for relapsed large B cell lymphoma [0.03%]
抗CD19导向的CAR-T细胞治疗后弥漫大B细胞淋巴瘤复发伴横贯性脊髓炎
Semira Sheikh,Sepideh Mokhtari,Jeffrey A Silverman et al.
Semira Sheikh et al.
Case Reports
EJHaem. 2021 Dec 6;3(1):223-227. DOI:10.1002/jha2.286 2021